Study Confirms GORE® BIO-A® Tissue Reinforcement a Proven Alternative to Biologics in Hernia Repair
Two-year study demonstrates improved patient satisfaction with Gore material
Gore Receives Health Canada Approval for GORE® VIABAHN® Endoprosthesis Innovations, Treating Peripheral Vascular Disease
Longer and Lower Profile Options Now Available in Canada to Treat More Patient Anatomies
Final Subject Enrolled in Early Feasibility Study of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis
Antegrade iteration accepted into study – advancing this branched, all-in-one system
One-Year Results in Japanese Clinical Study Affirms the GORE® VIABAHN® Endoprosthesis as a Device-of-Choice for Treating Complex SFA Disease
New clinical study shows excellent patency consistent with previous study results of self-expanding stent-graft in long, complex SFA lesions
Gore REVISE Clinical Study Demonstrates Superiority of GORE VIABAHN Endoprosthesis
GORE Device Outperforms Standard Treatment Option for Stenoses or Thrombotic Occlusions
First Patient Enrolled in Gore TAG Thoracic Branch Endoprosthesis LSA Feasibility Study
Multi-Center Study to Assess Feasibility of Gore Device to Treat Historically Challenging Patient Population
Gore Receives FDA Approval for Endovascular Treatment of In-Stent Restenosis with the GORE® VIABAHN® Endoprosthesis
Innovative treatment offers long-term solution for ISR
Gore Receives FDA Approval for 25 cm GORE® VIABAHN® Endoprosthesis
Longest stent-graft introduced in the United States
First Patient Enrolled in Gore TAG Thoracic Branch Endoprosthesis LSA Feasibility Study
Multi-Center Study to Assess Feasibility of Gore Device to Treat Historically Challenging Patient Population
Gore Launches Early Cannulation Capable GORE® ACUSEAL Vascular Graft
Results of early cannulation clinical trial presented at the 2013 VEITHsymposium